Safety and efficacy of Wharton's jelly-derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study.
Stem Cells Transl Med
; 10(4): 554-567, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33326694
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Spinal Fractures
/
Teriparatide
/
Mesenchymal Stem Cell Transplantation
/
Fractures, Compression
/
Bone Density Conservation Agents
/
Osteoporotic Fractures
/
Wharton Jelly
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Stem Cells Transl Med
Year:
2021
Type:
Article
Affiliation country:
South Korea